J&J ketamine-derived nasal spray approved to treat depression
Jan 21, 2025 · The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe …
Spravato Nasal Spray Can Now Be Used Alone for Treatment …
2 days ago · People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment. ... Last year, drugmaker Johnson & Johnson …
FDA approves standalone use of J&J’s ketamine-derived ... - CNN
Jan 22, 2025 · The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients …
SPRAVATO - Johnson & Johnson
Jan 21, 2025 · You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088. Please see full Prescribing Information, including Boxed …
Johnson & Johnson ketamine-derived nasal spray gets FDA …
Jan 22, 2025 · Johnson & Johnson beat analyst expectations for revenue by $70 million, but highlighted possible negative impacts in its outlook from an ongoing talc lawsuit and slower …
Ketamine-Derived Nasal Spray Approved as Standalone …
Jan 22, 2025 · This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that …
FDA approves Johnson & Johnson’s ketamine-derived nasal …
Jan 23, 2025 · It works by targeting glutamate—the most abundant excitatory neurotransmitter in the brain—although the mechanism by which esketamine works as an antidepressant effect is …
FDA approves first-of-its-kind nasal spray for severe depression
Jan 22, 2025 · Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive …
FDA approves Johnson & Johnson nasal spray Spravato for …
Jan 21, 2025 · Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.
FDA-Approved Nasal Spray For Depression Is First Of Its Kind
Jan 24, 2025 · A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & …